This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.

What's Trending

Tracking trends critical to life sciences and technology companies.

| 1 minute read

The Buzz Around Femtech at New York Tech Week 2025

The femtech sector's evolution presents opportunities for tech, healthcare, and life sciences companies that are both vast and largely untapped. What began as a narrow focus on period-tracking applications has blossomed into a comprehensive healthcare ecosystem addressing women's unique needs across all life stages. 

Those were key trends that recently emerged during New York Tech Week 2025, where Fenwick's Kristine DiBacco led a discussion on The Future of Femtech among founders and funders in this fast-growing space. Here's what we learned:

  • Market Maturing Beyond Early Misconceptions: The femtech landscape has evolved from the dismissive "we already have one women's health company" mindset to recognition of an entire ecosystem spanning reproductive wellness, maternal care, perimenopause management, and longevity solutions.
  • Emerging Clinical Research Innovation Opportunities: The historical exclusion of women from 97% of clinical studies until 1993 has created enormous opportunities for companies generating women-specific health data.
  • AI Transformational Potential: Unlike other healthcare applications, women's health offers perfect AI use cases due to historical data gaps, enabling personalized recommendations and scalable care delivery.
  • Global Expansion Advantages: International markets, particularly in Europe, offer more progressive attitudes toward women's health and streamlined regulatory pathways.
  • Navigating the Regulatory Environment: Complex but evolving regulations create both barriers and competitive advantages for companies willing to navigate and collaboratively work with regulators through the approval processes.
  • Employer Benefits B2B Market: Growing employer-provided women's health benefits create substantial opportunities for comprehensive solutions.
  • Values-Based Care Alignment: Healthcare's shift toward values and outcome-focused care naturally aligns with femtech solutions addressing historically underserved populations.

The femtech revolution is just beginning, and companies that can effectively address women's health needs with innovative, data-driven solutions will capture significant value as this market continues to mature globally.

Read our full panel takeaways.

Tags

corporate, regulatory, startup & venture capital, corporate venture, healthcare regulatory, patents & emerging technologies, private equity, private investment funds, healthtech, consumer technologies & retail, life sciences